A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/17 → 1/1/19

Funding

  • GlaxoSmithKline